Antibody adjuvant conjugates
US11547761B1 · kind B1 · utility
0Cited by
146References
91Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 3, 2021 |
| Grant date | Jan 10, 2023 |
| Priority date | — |
| Expiry date | Oct 8, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides an immunoconjugate comprising an antibody construct which includes an antigen binding domain and an Fc domain, an adjuvant moiety, and a linker, wherein each adjuvant moiety is covalently bonded to the antibody via the linker. Methods for treating cancer with the immunoconjugates of the invention are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.